Farnesol prevents Fe-NTA-mediated renal oxidative stress and early tumour promotion markers in rats

Human and Experimental Toxicology

Volumn 25, Issue 5, 2006, Pages 235-242

  Jahangir, Tamanna ^a   Khan, Tajdar Husain ^a   Prasad, Lakshmi ^a   Sultana, Sarwat ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Chemoprevention; Farnesol; Fe NTA; Oxidative damage; Tumour promotion markers

Indexed keywords

CATALASE; CREATININE; DNA; FARNESOL; GLUTATHIONE; GLUTATHIONE TRANSFERASE; ISOPRENOID; MALONALDEHYDE; NITRILOTRIACETATE IRON; ORNITHINE DECARBOXYLASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); THYMIDINE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IRON OVERLOAD; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TUMOR PROMOTION; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; BLOOD UREA NITROGEN; CARCINOGENS; DNA; FARNESOL; FERRIC COMPOUNDS; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; KIDNEY; LIPID PEROXIDATION; MALE; MICROSOMES; NITRILOTRIACETIC ACID; ORNITHINE DECARBOXYLASE; OXIDATIVE STRESS; OXIDOREDUCTASES; RATS; RATS, WISTAR; TUMOR MARKERS, BIOLOGICAL;

EID: 33744796235     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327106ht616oa     Document Type: Article

References (40)

1. Yamanoi Y, Matsuura R, Awai M. Mechanism of iron toxicity in the liver and pancreas after a single injection of ferric nitrilotriacetate. Nippon Ketsueki Gakkai Zasshi 1982; 45: 1229-35.
2. Rahman A, Ahmed S, Vasenwala SM, Athar M. Glyceryl trinitrate, a nitric oxide donor, abrogates ferric nitrilotriacetate-induced oxidative stress and renal damage. Arch Biochem Biophys 2003; 418: 71-79.
3. Anderson RL, Bishop WE, Campbell RL. A review of the environmental and mammalian toxicology of nitrilotriacetic acid. Crit Rev Toxicol 1985; 15: 1-102
4. Mottola HA. Nitrilotriacetic acid as a chelating agent: applications, toxicology and bioenvironmental impact. Toxicol Environ Chem 1974; 2: 99-161.
5. Nishiyama Y, Tanaka T, Naitoh H, Mori C, Fukumoto M, Hiai H, Toyokuni S. Overexpression of integrin-associated protein (CD47) in rat kidney treated with a renal carcinogen, ferric nitrilotriacetate. Jpn J Cancer Res 1997; 88: 120-28.
6. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 1991; 2: 427-42. Review.
7. Mo H, Elson CE. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med 2004; 229: 567-85.
8. Rao CV, Newmark HL, Reddy BS. Chemopreventive effect of farnesol and lanosterol on colon carcinogenesis. Cancer Detect Prev 2002; 26: 419-25.
9. Flach J, Antoni I, Villemin P, Bentzen CL, Niesor EJ. The mevalonate/isoprenoid pathway inhibitor apomine (SR-45023A) is antiproliferative and induces apoptosis similar to farnesol. Biochem Biophys Res Commun 2000; 270: 240-46.
10. Staines AG, Sindelar P, Coughtrie MW, Burchell B. Farnesol is glucuronidated in human liver, kidney and intestine in vitro, and is a novel substrate for UGT2B7 and UGT1A1. Biochem J 2004; 384: 637-45.
11. Biardi L, Krisans SK. Compartmentalization of cholesterol biosynthesis. Conversion of mevalonate to farnesyl diphosphate occurs in the peroxisomes. J Biol Chem 1996; 271: 1784-88.
12. Mo H, Elson CE. Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. J Nutr 1999; 129: 804-13.
13. Elson CE, Yu SG. The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables. J Nutr 1994; 124: 607-14.
14. Zhao J, Nan P, Zhong Y, Zhao J, Nan P, Zhong Y. Chemical composition of the essential oils of Clausena lansium from Hainan Island, China. Z Naturforsch [C] 2004; 59: 153-56.
15. Burke YD, Stark MJ, Roach SL, Sen SE, Crowell PL. Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids 1997; 32: 151-56.
16. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992; 18: 1-29.
17. Burke YD, Ayoubi AS, Werner SR, McFarland BC, Heilman DK, Ruggeri BA, Crowell PL. Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention. Anticancer Res 2002; 22: 3127-34.
18. Awai M, Narasaki Y, Yamanoi, Seno S. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis. Am J Pathol 1979; 95: 663-72.
19. Athar M, Iqbal M. Ferric nitrilotriacetate promotes N-diethylnitrosamine- induced renal tumorigenesis in the rat: implications for the involvement of oxidative stress. Carcinogenesis 1998; 19: 1133-39.
20. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic intermediate. Pharmacology 1974; 11: 151-69.
21. Habig WH, Pubst MJ, Jokoby WB. GST the first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-39.
22. Mohandas J et al. Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney. Cancer Res 1984; 44: 5086-91.
23. Carlberg I, Mannervik B. Glutathione reductase levels in rat brain. J Biol Chem 1975; 250: 5475-80.
24. Zaheer N, Tiwari KK, Krishnan PS. Exposure and solubilization of hepatic mitochondrial shunt dehydrogenases. Arch Biochem Biophys 1965; 109: 646-48.
25. Wright JR, Colby HD, Miles PR. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch Biochem Biophys 1981; 206: 296-304.
26. 2 production by chemically elicited peritoneal macrophages-induction by multiple non-phagocytic stimulus. Cell Immunol 1981; 59: 301-308.
27. Stripe F, Della Corte E. The regulation of rat liver xanthine oxidase. J Biol Chem 1969; 244: 3855-63.
28. Benson AM, Hunkeler MJ, Talalay P. Increase of NADPH; Quinone reductase activity by dietary antioxidant. Possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA 1980; 77: 5216-20.
29. Claiborne A. Catalase activity. In Greenwald RA ed. CRC handbook of methods in oxygen radical research. CRC Press, 1985: 283-84.
30. Kanter MW. Clinical chemistry. The Bobber Merill Company Inc., 1975: 80.
31. Hare RS. Endogenous creatinine in serum and urine. Proc Soc Exp Biol Med 1950; 74: 148.
32. O'Brien TG, Simsiman RC, Boutwel RK. Induction of the polyamine biosynthesis enzymes in mouse epidermis by tumor promoting agents. Cancer Res 1975; 35: 1662-70.
33. Smart RC, Huang MT, Conney AA. Sn 1,2, diacylglycerols mimic the effects of TPA in vivo by inducing biochemical changes associated with tumor promotion in mouse epidermis. Carcinogenesis 1986; 7: 1865-70.
34. Giles KW, Myers A. An improved diphenylamine method for the estimation of deoxyribonucleic acid. Nature 1965; 206: 63.
35. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the phenol reagent. J Biol Chem 1964; 193: 2370-78.
36. Khan N, Sharma S, Sultana S. Attenuation of potassium bromate-induced nephrotoxicity by coumarin (1,2-benzopyrone) in Wistar rats: chemoprevention against free radical-mediated renal oxidative stress and tumor promotion response. Redox Rep 2004; 9: 19-28.
37. Athar M, Khan WA, Mukhtar H. Effect of dietary tannic acid on epidermal, lung, and forestomach polycyclic aromatic hydrocarbon metabolism and tumorigenicity in Sencar mice. Cancer Res 1989; 49: 5784-88.
38. Yamada M, Awai M, Okigaki T. Rapid in vitro transformation system for liver epithelial cells by iron chelate, Fe-NTA. Cytotechnology 1990; 3: 149-56.
39. Kline DD, Prabhakar NR. Role of nitric oxide in short-term potentiation and long-term facilitation: involvement of NO in breathing stability. Adv Exp Med Biol 2001; 499: 215-19.
40. Iqbal M, Athar M. Attenuation of iron-nitrilotriacetate (Fe-NTA)-mediated renal oxidative stress, toxicity and hyperproliferative response by the prophylactic treatment of rats with garlic oil. Food Chem Toxicol 1998; 36: 485-95.